In Other News

• Electrochemical Biosensor Rapidly Detects Cerebrospinal Fluid Leaks

• FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology

• Whole Genome Sequencing Solution Targets Unsolved Rare Disease Cases

• Blood Protein Panel Supports Monitoring of Treated Celiac Disease

• Oral and Lung Microbiome Changes Linked to Severe Long Covid Symptoms

• Study Finds Distinct Malaria Parasites Linked to Sickle Cell Trait Protection

• Study Shows How Genome Reference Bias Can Mislead Preventive Testing

• Hemoglobin Levels May Help Signal Long-Term Dementia Risk

• Liquid Biopsy Platform Shows Promise for Early Gynecologic Cancer Detection

• Multi-Omics Study Identifies Blood Marker for MASLD Progression

• Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier

• Global Survey Finds Pediatric Troponin Testing Lacks Consistent Reference Intervals

• Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer

• Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

• European Approval Expands Liquid Biopsy Use in Advanced Breast Cancer Testing

• AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG

• Multi-Cancer Screening Blood Test Gains FDA Breakthrough Designation

• Blood-Based Immune Signal Could Reveal Lung Cancer Risk Before Tumors Develop

• AI Histopathology Tool Distinguishes Ewing Sarcoma for Diagnosis

• Prototype Point-of-Care Test Aims to Improve Neonatal Sepsis Diagnosis

• Genomic Screening Expands Detection of Treatable Conditions in Newborns

• Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

• Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome